Senior Vice President, Commercial
Mike McGuire brings over 30 years of expertise in both the commercialization of anti-infectives and knowledge of the hospital marketplace. Mike joined The Medicines Company in 2011 as Vice President, Business Development and Commercial Infectious Disease. In this role Mike was responsible for building the anti-infective franchise for the company. After the acquisition of Rempex Pharmaceuticals 2014, he led the commercial team that launched Vabomere™, Orbactiv® and Minocin IV. Mike will report to Dan Wechsler in the new organization.